Several data on small molecules regard ADAM17 activity, while evidence of ADAM10 regulation comes from neurobiological studies on AD and APP processing, a topic recently illustrated in dedicated reviews [13,63]. This evidence concerns the gene ADAM10 and Alzheimer disease.